RSDFX | VIVIX | RSDFX / VIVIX | |
Total Expense Ratio | 0.79 | 0.04 | 1,975% |
Annual Report Gross Expense Ratio | 0.79 | 0.04 | 1,975% |
Fund Existence | 17 years | 27 years | - |
Gain YTD | 8.185 | 6.730 | 122% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 5000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.15B | 195B | 1% |
Annual Yield % from dividends | 2.82 | 2.19 | 129% |
Returns for 1 year | 8.02 | 9.75 | 82% |
Returns for 3 years | 23.08 | 34.32 | 67% |
Returns for 5 years | 46.90 | 74.87 | 63% |
Returns for 10 years | 37.10 | 116.26 | 32% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
GSMQX | 19.23 | 0.23 | +1.21% |
Goldman Sachs Small/Mid Cap Growth Svc | |||
JGMIX | 25.48 | 0.18 | +0.71% |
Janus Henderson Triton S | |||
FTTEX | 13.90 | -0.02 | -0.14% |
Fidelity Advisor Total Intl Equity M | |||
ENHNX | 10.69 | -0.02 | -0.19% |
Cullen Enhanced Equity Income I | |||
RALOX | 10.75 | -0.03 | -0.28% |
Lazard Real Assets Open |